Article from CKD Update ()
February 4, 2003
Chronic Kidney Disease (CKD): The Facts
CKD - Prevent the progression from CKD to kidney failure and cardiovascular disease

* 20 million Americans - 1 in 9 US adults - have CKD and another 20 million more are at increased risk.

* Early detection can help prevent the progression of kidney disease to kidney failure.

* Glomerular filtration rate (GFR) is the best estimate of kidney function. But because of logistics issues, not all labs are reporting GFR at this time. A free GFR calculator is available at http://www.kdoqi.org. The key is to know BOTH serum creatinine and GFR.

* Hypertension causes CKD and CKD causes hypertension.

* Persistant proteinuria means CKD.

* High risk groups include those with diabetes, hypertension and family history of kidney disease.

*African Americans, Hispanics, Pacific Islanders, Native Americans and Seniors are at increased risk.

* Three simple tests can detect CKD: blood pressure, urine and serum creatinine.

Stages of Chronic Kidney Disease:A Clinical Action Plan

 


Stage


Description

GFR
(mL/min/1.73 m2)


Action*

 

At increased risk

≥90
(with CKD risk factors)

Screening,
CKD risk reduction

1

Kidney damage with normal or increased GFR

≥90

Diagnosis and treatment,
Treatment of comorbid conditions,
Slowing progression,
CVD risk reduction

2

Kidney damage with mildly decreased GFR

60–89

Estimating progression

3

Moderately decreased GFR

30–59

Evaluating and treating complications

4

Severely decreased GFR

15–29

Preparation for kidney
replacement therapy

5

Kidney failure

<15
(or dialysis)

Replacement (if uremia present)

Chronic kidney disease is defined as either kidney damage or GFR <60 mL/min/1.73 m2 for >3 months. Kidney damage is defined as pathologic abnormalities or markers of damage, including abnormalities in blood or urine tests or imaging studies.
* Includes actions from preceding stages.
Abbreviations: GFR, glomerular filtration rate; CKD, chronic kidney disease; CVD, cardiovascular disease  
National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S1-S000, 2002 (suppl 1)
 

Published by National Kidney Foundation
Copyright © 2009 the National Kidney Foundation. All rights reserved.
PRIVACY POLICY: The National Kidney Foundation respects your privacy. We do not sell our subscriber lists to outside or third-parties. If you would prefer not to receive future issues of CKD Update, select Remove in the Subscribe box located on the front page of this publication. CKD Update Editorial Board: Ann Compton, MSN, RNC; Cynda Ann Johnson, MD, MBA; Nelson Kopyt, DO; Kathy Schiro Harvey MS, RD, CSR; Anton Schoolwerth, MD; Beth Witten, MSW, ACSW, LSCSW
Powered by IMN